Nanalysis Scientific Corp.
NSCIF
$0.13
-$0.01-7.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.92M | 7.38M | 8.78M | 7.75M | 8.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.92M | 7.38M | 8.78M | 7.75M | 8.39M |
| Cost of Revenue | 5.24M | 5.49M | 5.79M | 5.56M | 6.04M |
| Gross Profit | 1.68M | 1.89M | 2.99M | 2.19M | 2.35M |
| SG&A Expenses | 2.20M | 1.94M | 1.90M | 2.05M | 2.32M |
| Depreciation & Amortization | 713.40K | 598.50K | 775.80K | 805.00K | 792.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.25M | 8.12M | 8.54M | 8.49M | 9.16M |
| Operating Income | -1.33M | -742.10K | 239.30K | -744.20K | -773.90K |
| Income Before Tax | -1.56M | -873.80K | -5.34M | -1.20M | -1.46M |
| Income Tax Expenses | -24.60K | 36.90K | -19.30K | 2.20K | -4.40K |
| Earnings from Continuing Operations | -1.53M | -910.70K | -5.32M | -1.21M | -1.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.53M | -910.70K | -5.32M | -1.21M | -1.46M |
| EBIT | -1.33M | -742.10K | 239.30K | -744.20K | -773.90K |
| EBITDA | -1.19M | -622.20K | 421.50K | -552.80K | 69.40K |
| EPS Basic | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 113.54M | 113.22M | 113.13M | 113.10M | 113.03M |
| Average Diluted Shares Outstanding | 113.54M | 113.22M | 113.13M | 113.10M | 113.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |